London, 2020. In the heat of the COVID-19 pandemic, Dr. Sofia Mendes is stretched thin. An infectious-disease specialist, she’s fighting the consequences of a relentless virus. The collapse of everything around her: her colleagues, patients, and her own endurance. When the hospital begins to buckle under pressure, Sofia seeks to resurrect an abandoned research project, Vitalis. The concept had always seemed impossible: a molecular decoy capable of predicting how a virus might mutate and fight it. With nothing left to lose, Sofia revives the work with a former collaborator. Together, backed by a biotech investor with funding and extensive influence, but under crushing pressure, they push the experiment from theory to trial.
Every breakthrough meets a wall, regulatory delays, political interference, and an unforgiving race for approval. The world is watching. Remnavax is born: a vaccine able to anticipate viral change before it happens. The discovery reshapes science, modern politics, and Sofia’s life in a dramatic way.
But victory leaves scars. As the world progresses and applause fades, Sofia notices a subtle but strange pattern in the long-term data that should not exist, suggesting the vaccine may have changed more than the virus itself.
Remnavax: The Discovery is the first of a Trilogy of novels and is taut, human, and quietly haunting, chronicling the story of a woman whose discovery saves the world, reshapes history, and awakens a future unlike any before it.
One Response
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.